Cargando…
Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
BACKGROUND: Safe, effective, and readily available drug therapies are required for the management of hyperlipidemia and its associated complications in dogs. OBJECTIVES: To investigate the efficacy of a micronized, nanocrystal formulation of fenofibrate (Tricor) in the treatment of hyperlipidemia in...
Autores principales: | Munro, Matthew J. L., Hulsebosch, Sean E., Marks, Stanley L., Gilor, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295657/ https://www.ncbi.nlm.nih.gov/pubmed/34096101 http://dx.doi.org/10.1111/jvim.16190 |
Ejemplares similares
-
Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs
por: Hulsebosch, Sean E., et al.
Publicado: (2022) -
Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017) -
Characterization of clinicopathologic and abdominal ultrasound findings in dogs with glucocorticoid deficient hypoadrenocorticism
por: Reagan, Krystle L., et al.
Publicado: (2022) -
Evaluation of gallbladder motility assessed by ultrasonography in dogs with hyperlipidemia
por: Villm, Jessica A., et al.
Publicado: (2023) -
Disseminated Rasamsonia argillacea species complex infections in 8 dogs
por: Dear, Jonathan D., et al.
Publicado: (2021)